open access

Vol 61, No 5 (2010)
Other materials agreed with the Editors
Submitted: 2013-02-15
Published online: 2010-11-04
Get Citation

The application of SPECT/CT scintigraphy with MIBI-Tc99m in the diagnosis of thyroid nodules - a preliminary report

Maria H. Listewnik, Bożena Birkenfeld, Hanna Piwowarska-Bilska, Katarzyna Cichoń-Bańkowska, Lidia Iglińska-Wagner, Wanda Watrak, Wiesława Smolira, Piotr Zorga, Krystyna Niedziałkowska, Bogumiła Elbl, Marek Sawrymowicz
Endokrynol Pol 2010;61(5):422-426.

open access

Vol 61, No 5 (2010)
Congressional papers
Submitted: 2013-02-15
Published online: 2010-11-04

Abstract


Introduction: Thyroid cancer diagnosis is based mainly on fine needle aspiration biopsy (FNAB) performed under ultrasonography guidance. Questions arise in cases of an inconclusive FNAB result - when there is no clear evidential data to support the existence of a malignant lesion or when there are any other reasons which make the decision process difficult, such as the patient’s age or coexisting diseases. To clarify this issue the patient should be encouraged to undergo surgery treatment or to be followed up. Thyroid scintigraphy with an oncophilic tracer such as MIBI-Tc99m may be helpful.
Material and methods: The study comprised a group of 12 patients, aged 54-75 (av. 63.5) years, who, in 2009, underwent planar and SPECT/CT thyroid scintigraphy with MIBI-Tc99m using washout method. The tumour/background ratio in early and delayed images was calculated and the wash-out ratio was estimated. Patients with increased focal lesion uptake were operated on and the lesions were histopathologically verified.
Results: Abnormal scintigraphy results were obtained in 8 patients (10 lesions) and normal results in 4 patients (5 lesions). Out of 15 studies, in 13 cases the washout from the lesion was observed within 2 hours. It was noticed that the images obtained with SPECT/CT washout method were clearer and easier to read in comparison to planar studies. Three patients with an abnormal results underwent surgery and had benign histopathology results after the operation, in 3 patients the observation is being confirmed without any increase in malignancy suspicions, and 2 were lost for observation.
Conclusions: Our preliminary results do support the use of MIBI-Tc99m in the evaluation of indeterminate thyroid nodules. To validate the hypothesis that MIBI-Tc99m may be used to exclude malignancy in lesions indeterminate by FNAB we propose to use SPECT-CT derived images and standardized evaluation criteria.
(Pol J Endocrinol 2010; 61 (5): 422-426)

Abstract


Introduction: Thyroid cancer diagnosis is based mainly on fine needle aspiration biopsy (FNAB) performed under ultrasonography guidance. Questions arise in cases of an inconclusive FNAB result - when there is no clear evidential data to support the existence of a malignant lesion or when there are any other reasons which make the decision process difficult, such as the patient’s age or coexisting diseases. To clarify this issue the patient should be encouraged to undergo surgery treatment or to be followed up. Thyroid scintigraphy with an oncophilic tracer such as MIBI-Tc99m may be helpful.
Material and methods: The study comprised a group of 12 patients, aged 54-75 (av. 63.5) years, who, in 2009, underwent planar and SPECT/CT thyroid scintigraphy with MIBI-Tc99m using washout method. The tumour/background ratio in early and delayed images was calculated and the wash-out ratio was estimated. Patients with increased focal lesion uptake were operated on and the lesions were histopathologically verified.
Results: Abnormal scintigraphy results were obtained in 8 patients (10 lesions) and normal results in 4 patients (5 lesions). Out of 15 studies, in 13 cases the washout from the lesion was observed within 2 hours. It was noticed that the images obtained with SPECT/CT washout method were clearer and easier to read in comparison to planar studies. Three patients with an abnormal results underwent surgery and had benign histopathology results after the operation, in 3 patients the observation is being confirmed without any increase in malignancy suspicions, and 2 were lost for observation.
Conclusions: Our preliminary results do support the use of MIBI-Tc99m in the evaluation of indeterminate thyroid nodules. To validate the hypothesis that MIBI-Tc99m may be used to exclude malignancy in lesions indeterminate by FNAB we propose to use SPECT-CT derived images and standardized evaluation criteria.
(Pol J Endocrinol 2010; 61 (5): 422-426)
Get Citation

Keywords

Technetium-99m-sestamibi; thyroid nodules; SPECT/CT

About this article
Title

The application of SPECT/CT scintigraphy with MIBI-Tc99m in the diagnosis of thyroid nodules - a preliminary report

Journal

Endokrynologia Polska

Issue

Vol 61, No 5 (2010)

Article type

Other materials agreed with the Editors

Pages

422-426

Published online

2010-11-04

Page views

660

Article views/downloads

2338

Bibliographic record

Endokrynol Pol 2010;61(5):422-426.

Keywords

Technetium-99m-sestamibi
thyroid nodules
SPECT/CT

Authors

Maria H. Listewnik
Bożena Birkenfeld
Hanna Piwowarska-Bilska
Katarzyna Cichoń-Bańkowska
Lidia Iglińska-Wagner
Wanda Watrak
Wiesława Smolira
Piotr Zorga
Krystyna Niedziałkowska
Bogumiła Elbl
Marek Sawrymowicz

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl